Avid Bioservices Inc [CDMO] stock is trading at $12.25, down -0.08%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CDMO shares have gain 18.47% over the last week, with a monthly amount glided 18.70%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, KeyBanc Capital Markets upgraded its rating to Overweight on March 14, 2023, and kept the price target unchanged to $20. On December 08, 2021, downgrade downgraded it’s rating to Sector Weight. RBC Capital Mkts started tracking the stock assigning a Outperform rating and suggested a price target of $21 on March 17, 2021. KeyBanc Capital Markets initiated its recommendation with a Overweight and recommended $12 as its price target on November 10, 2020. First Analysis Sec upgraded its rating to Strong Buy for this stock on December 10, 2019. In a note dated October 17, 2019, Stephens initiated an Overweight rating and provided a target price of $8 on this stock.
Avid Bioservices Inc [CDMO] stock has fluctuated between $4.07 and $12.48 over the past year. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Avid Bioservices Inc [NASDAQ: CDMO] shares were valued at $12.25 at the most recent close of the market. An investor can expect a potential drop of -34.69% based on the average CDMO price forecast.
Analyzing the CDMO fundamentals
Avid Bioservices Inc [NASDAQ:CDMO] reported sales of 142.36M for the trailing twelve months, which represents a growth of 6.49%. Gross Profit Margin for this corporation currently stands at 0.06% with Operating Profit Margin at -0.13%, Pretax Profit Margin comes in at -0.21%, and Net Profit Margin reading is -1.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.43, Equity is -1.19 and Total Capital is -0.07. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of2.67.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.23 points at the first support level, and at 12.21 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.28, and for the 2nd resistance point, it is at 12.31.
Ratios To Look Out For
For context, Avid Bioservices Inc’s Current Ratio is 1.46. Also, the Quick Ratio is 1.05, while the Cash Ratio stands at 0.47. Considering the valuation of this stock, the price to sales ratio is 5.51, the price to book ratio is 13.33.
Transactions by insiders
Recent insider trading involved Kwietniak Matthew R., Chief Commercial Officer, that happened on Oct 14 ’24 when 119.0 shares were sold. Chief Operations Officer, Richieri Richard A. completed a deal on Oct 10 ’24 to sell 2031.0 shares. Meanwhile, Chief Operations Officer Richieri Richard A. sold 201.0 shares on Oct 10 ’24.
